Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 11,561

Document Document Title
WO/2015/018940A1
The present invention relates to use of compounds of formula (I) or a coordination complex thereof with a metal ion selected from the group consisting of Ni(ll), Cu(ll), Sc(lll), Fe(ll), Fe(lll), Ca(ll), Co(ll), Co(lll), Os(lll), Os(IV),...  
WO/2015/020689A1
A catalyst includes a reaction product of a metal precursor and a ligand. The catalyst may be used to react polyurethane compositions, polyester compositions, and condensation reactable polyorganosiloxane compositions.  
WO/2015/014835A1
The present invention relates to metal-carbene complexes of the general formula (I), where variable M is Ir or Pt and that are characterized by variable R being a group of formula (a). The complexes are used in organic electronic devices...  
WO/2015/014944A1
A cyclometallated Ir complex comprising one, two or three ligands of formula (I) or (I') substituted at the R5 and R7 position; an organic electronic device comprising at least one inventive cyclometallated Ir complex; alight-emitting la...  
WO/2015/011032A1
The present invention relates to a process for preparing substituted biphenylanilides of the formula I in which R1 is selected from a protected amino group, NO2, NH2 and NHR3, in which a compound of the formula II is reacted in the prese...  
WO/2015/012396A1
An adsorption/separation method for hydrocarbon mixed gas having at least four carbon atoms, characterized by causing hydrocarbons to be selectively adsorbed by a metal complex, by causing the mixed gas to come in contact with the metal ...  
WO/2015/013565A1
New derivatives of a Pt (II) complex provided which are liposoluble and useful as anticancer agents. Also disclosed are platinum II complexes in delivery systems such as liposomes, emulsions, nanoemulsions, and lipid excipients.  
WO/2014/160216A3
Methods, compounds, and compositions for treating a proliferative disorder or other physiological conditions via a dual targeting anticancer therapy are provided. In some embodiments, a dual targeting anticancer therapy may utilize a com...  
WO/2015/009841A2
The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for treating cancer.  
WO/2014/145428A3
Compositions of the invention include metal-based coordination complexes, which are preferably tunable photodynamic compounds. The compositions and complexes are useful as therapeutic agents and as in vivo diagnostic agents for treating ...  
WO/2015/006015A1
Compounds, systems, and methods are provided for the design and assembly of a non-invasive, analyte sensing dressing. The dressing can be therapeutic. The dressing includes a sensor and a matrix. The sensor is capable of detecting analyt...  
WO/2015/005616A1
Provided are a novel complex synthesized from a Salen-type ligand containing a quaternary ammonium salt and a preparation method of a copolymer of carbon dioxide and epoxide using the same as a catalyst.  
WO/2015/006458A1
The invention relates to a series of novel chiral nitrogen-phosphorus ligands of formulae (Ia) and (Ib): wherein R1-R3 and X are as defined herein. The invention also relates to chiral metal complexes prepared with these chiral nitrogen-...  
WO/2015/000955A1
An organic electronic device, preferably an organic light-emitting diode (OLED), comprising at least one metal-carbene complex comprising one, two or three specific bidentate diazabenzimidazole carbene ligands;a light-emitting layer comp...  
WO/2015/000928A1
The invention relates to compounds characterized by a general formula (1), wherein X is a group described by a general formula -Kp-Fr Kq-, wherein - Fl is -C(=0)-,-C(=S)-, with I being 0 or 1, - Kp is a Cp-alkyl with p being 0, 1, 2, 3 o...  
WO/2015/002081A1
This ligand is represented by formula (AL); this metal complex dye has this ligand; this dye solution contains this metal complex dye; this dye-adsorbed electrode is obtained using this dye solution; this method for manufacturing a dye-s...  
WO/2015/002769A1
Disclosed are novel ruthenium compounds of formula (Ia) and (Ib): wherein R1 and the moiety L ∩ L are defined herein. Also disclosed is a process for using these novel ruthenium compounds as catalysts for asymmetric hydrogenation and t...  
WO/2015/000546A1
The present invention relates to compounds having polycyclic structural units and to electronic devices, in particular organic electroluminescent devices, containing said compounds.  
WO/2014/207393A1
The invention relates to a novel disymmetric nickel-based complex and to the method for the production thereof from at least one diphosphinamine ligand B1 of formula (R1)(R'1)P-N(R3)-P(R2)(R'2), or an iminobisphosphine ligand B2 of formu...  
WO/2014/203963A1
By using a metal complex including a ruthenium ion or an osmium ion and a tridentate aminodicarbene ligand that includes one secondary amine group and two specific heterocyclic carbene groups sandwiching the amine group, it is possible t...  
WO/2014/203540A1
A metal complex composition which comprises a metal complex that includes a substructure represented by formula (1) and impurities, wherein the content of the metal complex is 99.7% or more, the impurities are generated by the metal comp...  
WO/2014/205025A1
An aryl phosphine with fused ring ortho-alkoxy substitution that includes an aryl monophosphine and an aryl bisphosphine.  
WO/2014/203691A1
Provided are a platinum complex that has an excellent antitumor effect and reduced toxicity such as myelosuppression, and a medicine containing the same. A platinum complex derivative represented by general formula (1) [wherein: R1 and R...  
WO/2014/165782A3
Compositions, kits, and methods for treatment of cancers are generally provided. In some embodiments, the compositions, kits, and methods comprise a platinum (e.g., Pt (II) or Pt (IV)) compound associated with a ligand (e.g., a beta-dike...  
WO/2014/198658A1
The present invention provides novel ruthenium or osmium based complex structures with a unique combination of ligands comprising a Schiff-base type ligand, a N-heterocyclic carbene ligand and a CO ligand which can be prepared according ...  
WO/2014/201376A2
The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to platinum based compounds comprising platinum moiety, linker moiety and lipid moiety and corres...  
WO/2014/201300A1
The present application provides, among other things, compounds and methods for metathesis reactions. In some embodiments, provided compounds promote highly efficient and highly Z-selective metathesis. In some embodiments, provided compo...  
WO/2014/201082A1
Transition metal compounds, and specifically transition metal compounds having a tetradentate and/or pentadentate supporting ligand are described, together with methods for the preparation thereof and the use of such compounds as hydroge...  
WO/2014/198140A1
Disclosed are a platinum(II) compound, a preparation method therefor, and a pharmaceutical composition and an application thereof. The preparation method comprises the following steps: enabling dihydrate diammineplatinum nitrate (4) to r...  
WO/2014/199352A2
The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to carbene compounds, particularly platinum containing carbenes and corresponding nanoparticles t...  
WO/2014/198057A1
Disclosed is a process for the production of furanic compound comprising at least one amine function, comprising reacting a furanic compound having at least one hydroxyl function or at least one aldehyde function with a second reactant h...  
WO/2014/198022A1
Disclosed are ruthenium or osmium based complex structures with a unique combination of ligands comprising a Schiff-base type ligand, a N-heterocyclic carbine ligand and a CO ligand. Further disclosed are the preparation processes of the...  
WO/2014/199842A1
An organometallic iridium complex that has high emission efficiency and a long lifetime and emits deep red light (emission wavelength: around 700 nm) is provided. The organometallic iridium complex has a ligand that is represented by Gen...  
WO/2014/196685A1
The present invention relates to a compound for an organic optoelectronic device, an organic light-emitting diode comprising the same, and a display device comprising the organic light-emitting element. The present invention provides a c...  
WO/2014/138113A3
Described herein are platinum complexes of Formula (I) as catalysts for a selective 1,2-hydrosilylation of 1,3-dienes. Methods of using the platinum complexes for selective 1,2- hydrosilylation of 1,3- dienes are also provided. A represe...  
WO/2014/191725A1
A process for the preparation of a metal-organic compound, said metal- organic compound comprising at least one metal ion and at least one organic ligand, wherein said organic ligand is capable of associating with said metal ion, compris...  
WO/2014/188783A1
 The purpose of the invention is to provide a production method that makes possible the industrial production of an optically active α-amino acid at high yield and high enantioselectivity, to provide a simple method for producing opti...  
WO/2014/187830A1
The present invention relates to novel Ruthenium-based complex compounds which represent viable catalysts, in particular for all sorts of metathesis reactions. Such complex compounds can be prepared by a novel, very favourable and cost e...  
WO/2014/189340A1
The present invention relates to a novel ruthenium compound, a method for manufacturing the ruthenium compound, a precursor composition for depositing a film, the precursor composition comprising the ruthenium compound, and a method for ...  
WO/2014/187973A1
Novel transition metal complexes are provided which represent viable catalysts for a broad variety of reactions such as hydrogenation reactions and metathesis reactions. Novel preparation processes are made available via unprecedented ro...  
WO/2014/188629A1
 The present invention provides a chemical vapor deposition raw material that has a low melting point, has a heat stability such that no thermal decomposition occurs during the vaporization stage, readily decomposes at a low temperatur...  
WO/2014/186631A1
This invention relates generally to enantiomerically enriched C-H activated ruthenium olefin metathesis catalyst compounds which are stereogenic at ruthenium, to the preparation of such compounds, and the use of such catalysts in the met...  
WO/2014/182681A1
The present invention relates to processes for the synthesis of saturated and unsaturated silahydrocarbons using iron-containing or cobalt-containing catalysts. The processes of the invention can produce tetraalkylsilanes, phenyltrialkyl...  
WO/2014/177518A1
The present invention relates to iridium and platinum carbene complexes of the general formula (I), to OLEDs (Organic Light-Emitting Diodes) which comprise such complexes, to a device selected from the group consisting of illuminating el...  
WO/2014/177355A1
The invention relates to new quadridentate phosphorous ligands comprising a hostanox O3 conductive structure, to a method for the production thereof and to the use thereof as ligands in the hydroformylation.  
WO/2014/175267A1
The purpose of the invention is to provide a novel organometallic compound that can be utilized as a catalyst having high generality, high activity, and excellent functional group selectivity. The invention pertains to a novel organometa...  
WO/2014/175841A1
The invention relates to palladium(II) complexes of curcumin and its analogues of general formula (Formula (A)) wherein R1 and R2 are each independently hydrogen, hydroxy, methoxy or ethoxy, as well as the process for preparing the same ...  
WO/2014/176159A1
There is provided a compound having Formula I [INSERT FORMULA I HERE] In Formula I: R1, R2, R4, R6, and R8-R11 are the same or different and can be H, D, alkyl, deuterated alkyl, silyl, or deuterated silyl; R3 and R7 can be alkyl, deuter...  
WO/2014/166777A1
The present invention relates to a process for the preparation of a compound of formula (I), wherein X is -CH2-, -CH2-CH2-, -CH2-CH2-CH2- or -CH2-CH2-CH2-CH2-; Y1 is -CH2-; -CH2-CH2- or -NH-; Y2 is NHR7 or SH; wherein R7 is hydrogen, C1-...  
WO/2014/166577A1
The present invention relates metal complexes and to electronic devices, particularly organic electroluminescent devices containing said metal complexes.  

Matches 601 - 650 out of 11,561